HEP1

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameHEP1
Drug Alias NameHuman Ezrin Peptide Onehuman ezrin peptide 324–337HeponGepon
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Coronavirus InfectionsVirus Diseases +[4] 
Global Approved IndicationsVirus DiseasesHIV Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryRussian Federation
Original Approved Date2001/01/01
Country/TerritoryRussian FederationIran
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesImmapharma
China Registration ClassN/A

Develop Information

Active CompaniesImmapharma
Inactive CompaniesShahid Beheshti University Of Medical Sciences
Active IndicationsVirus DiseasesHIV Infections
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Coronavirus Infections

Other Information

ATC CodeJ05A
Related LinksN/A